Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

159 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Chemoradiotherapy with 3-weekly CDDP 80 mg/m2 for head and neck squamous cell carcinoma: 5-year survival data from a phase 2 study.
Otaki K, Takahashi T, Tanaka R, Saijo K, Omata J, Yokoyama Y, Shodo R, Ueki Y, Yamazaki K, Ota H, Togashi T, Takahashi N, Okabe R, Matsuyama H, Horii A. Otaki K, et al. Among authors: saijo k. Front Surg. 2022 Dec 16;9:1035349. doi: 10.3389/fsurg.2022.1035349. eCollection 2022. Front Surg. 2022. PMID: 36589621 Free PMC article.
Head and neck small-cell carcinoma: A multicenter study of 39 cases from 10 institutions.
Matsuyama H, Ueki Y, Okamoto I, Nagao T, Honda K, Yamazaki K, Okabe R, Togashi T, Shodo R, Ota H, Takahashi T, Omata J, Yokoyama Y, Saijo K, Tanaka R, Tsukahara K, Kitahara T, Uemura H, Yoshimoto S, Matsumoto F, Okami K, Sakai A, Takano K, Kondo A, Inohara H, Eguchi H, Oridate N, Tanabe T, Nakamizo M, Yokoshima K, Miura K, Kitani Y, Horii A. Matsuyama H, et al. Among authors: saijo k. Front Surg. 2022 Nov 14;9:1049116. doi: 10.3389/fsurg.2022.1049116. eCollection 2022. Front Surg. 2022. PMID: 36451679 Free PMC article.
Multicenter prospective phase II trial of concurrent chemoradiotherapy with weekly low-dose carboplatin for cisplatin-ineligible patients with advanced head and neck squamous cell carcinoma.
Ueki Y, Ohshima S, Yokoyama Y, Takahashi T, Shodo R, Yamazaki K, Ohtaki K, Saijo K, Tanaka R, Togashi T, Sato Y, Takano S, Omata J, Takahashi N, Okabe R, Horii A. Ueki Y, et al. Among authors: saijo k. Int J Clin Oncol. 2024 Jan;29(1):20-26. doi: 10.1007/s10147-023-02423-w. Epub 2023 Oct 16. Int J Clin Oncol. 2024. PMID: 37843751 Clinical Trial.
Role of copper during microglial inflammation.
Craciun L, Muroy SE, Saijo K. Craciun L, et al. Among authors: saijo k. bioRxiv [Preprint]. 2024 Sep 19:2024.09.18.613750. doi: 10.1101/2024.09.18.613750. bioRxiv. 2024. PMID: 39345477 Free PMC article. Preprint.
Carrier-free nano-prodrugs for minimally invasive cancer therapy.
Tanita K, Koseki Y, Kumar S, Taemaitree F, Mizutani A, Nakatsuji H, Suzuki R, Dao ATN, Fujishima F, Tada H, Ishida T, Saijo K, Ishioka C, Kasai H. Tanita K, et al. Among authors: saijo k. Nanoscale. 2024 Aug 15;16(32):15256-15264. doi: 10.1039/d4nr01763c. Nanoscale. 2024. PMID: 39073351
159 results